当前位置：药药网 / 药品研发 / 美国药品上市后承诺数据库
Anthrasil, Anthrax Immune Globulin Intravenous (Human)
申请企业
Emergent BioSolutions Canada Inc.
药品名称
Anthrasil, Anthrax Immune Globulin Intravenous (Human)
承诺描述
To submit annual progress reports as well as interim clinical summary reports including available cumulative clinical and pharmacokinetic data every three years from use of Anthrax Immune Globulin (Human) in sporadic systemic anthrax cases (protocol AX-003B).